Cheah C - Search Results

1

Unmet supportive care needs of people with advanced cancer and their caregivers: A systematic scoping review.

Hart NH, Crawford-Williams F, Crichton M, Yee J, Smith TJ, Koczwara B, Fitch MI, Crawford GB, Mukhopadhyay S, Mahony J, Cheah C, Townsend J, Cook O, Agar MR, Chan RJ. Hart NH, et al. Among authors: cheah c. Crit Rev Oncol Hematol. 2022 Aug;176:103728. doi: 10.1016/j.critrevonc.2022.103728. Epub 2022 Jun 1. Crit Rev Oncol Hematol. 2022. PMID: 35662585 Review.

2

Real world data as a key element in precision medicine for lymphoid malignancies: potentials and pitfalls.

El-Galaly TC, Cheah CY, Villa D. El-Galaly TC, et al. Among authors: cheah cy. Br J Haematol. 2019 Aug;186(3):409-419. doi: 10.1111/bjh.15965. Epub 2019 May 29. Br J Haematol. 2019. PMID: 31140600 Free article. Review.

3

A consensus statement on the use of biosimilar medicines in hematology in Australia.

Gregory GP, Carrington C, Cheah CY, Hawkes EA, Irving IM, Siderov J, Opat S. Gregory GP, et al. Among authors: cheah cy. Asia Pac J Clin Oncol. 2020 Aug;16(4):211-221. doi: 10.1111/ajco.13337. Epub 2020 Apr 14. Asia Pac J Clin Oncol. 2020. PMID: 32285612 Review.

4

Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review.

Bataillard EJ, Cheah CY, Maurer MJ, Khurana A, Eyre TA, El-Galaly TC. Bataillard EJ, et al. Blood Adv. 2021 May 11;5(9):2426-2437. doi: 10.1182/bloodadvances.2021004665. Blood Adv. 2021. PMID: 33961018 Free PMC article.

5

About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?

Lewis KL, Cheah CY. Lewis KL, et al. Expert Rev Hematol. 2022 Nov;15(11):959-962. doi: 10.1080/17474086.2022.2140138. Epub 2022 Oct 27. Expert Rev Hematol. 2022. PMID: 36278876 No abstract available.

6

Marginal zone lymphoma: 2023 update on diagnosis and management.

Cheah CY, Seymour JF. Cheah CY, et al. Am J Hematol. 2023 Oct;98(10):1645-1657. doi: 10.1002/ajh.27058. Epub 2023 Aug 21. Am J Hematol. 2023. PMID: 37605344

7

Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?

Chihara D, Oki Y, Fanale MA, Westin JR, Nastoupil LJ, Neelapu S, Fayad L, Fowler NH, Cheah CY. Chihara D, et al. Ann Hematol. 2019 May;98(5):1169-1176. doi: 10.1007/s00277-018-3571-7. Epub 2019 Jan 8. Ann Hematol. 2019. PMID: 30617643

8

Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration.

Cheah CY, Bröckelmann PJ, Chihara D, Moskowitz AJ, Engert A, Jerkeman M, El-Galaly TC, Augustson B, Vose J, Bartlett NL, Villa D, Connors JM, Feldman T, Pinnix CC, Milgrom SA, Dabaja B, Oki Y, Fanale MA. Cheah CY, et al. Am J Hematol. 2016 Sep;91(9):894-9. doi: 10.1002/ajh.24429. Epub 2016 Jun 20. Am J Hematol. 2016. PMID: 27222367 Free article.

9

When to treat patients with relapsed follicular lymphoma.

Cheah CY, Seymour JF. Cheah CY, et al. Expert Rev Hematol. 2017 Mar;10(3):187-191. doi: 10.1080/17474086.2017.1291339. Epub 2017 Feb 15. Expert Rev Hematol. 2017. PMID: 28164722 Review.

10

Management of indolent B-cell Lymphomas: A review of approved and emerging targeted therapies.

Smyth E, Cheah CY, Seymour JF. Smyth E, et al. Cancer Treat Rev. 2023 Feb;113:102510. doi: 10.1016/j.ctrv.2023.102510. Epub 2023 Jan 5. Cancer Treat Rev. 2023. PMID: 36634434 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

323 results

Search Page